Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.12 USD | -1.68% | +0.96% | -26.80% |
Apr. 11 | Zentalis Pharmaceuticals, Inc. Announces Executive Changes | CI |
Apr. 11 | Zentalis Pharmaceuticals, Inc. Announces CFO Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.80% | 803M | |
-1.48% | 104B | |
+6.94% | 97.47B | |
+5.71% | 22.25B | |
-13.12% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-9.90% | 16.36B | |
+8.17% | 14.39B | |
+38.91% | 12.37B |
- Stock Market
- Equities
- ZNTL Stock
- News Zentalis Pharmaceuticals, Inc.
- Wedbush Downgrades Zentalis Pharmaceuticals to Neutral From Outperform After Announced Updates to Azenosertib Strategy in Platinumsensitive Ovarian Cancer; Cuts PT to $12 From $38